Compare HAE & TKC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HAE | TKC |
|---|---|---|
| Founded | 1971 | 1993 |
| Country | United States | Turkey |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.7B |
| IPO Year | 1996 | 2001 |
| Metric | HAE | TKC |
|---|---|---|
| Price | $102.92 | $5.10 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $84.13 | N/A |
| AVG Volume (30 Days) | 663.1K | ★ 1.9M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 2.52% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $910,373,000.00 | N/A |
| Revenue This Year | N/A | $31.20 |
| Revenue Next Year | $5.23 | $24.27 |
| P/E Ratio | $142.94 | ★ $26.98 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $47.32 | $4.90 |
| 52 Week High | $109.57 | $7.18 |
| Indicator | HAE | TKC |
|---|---|---|
| Relative Strength Index (RSI) | 62.29 | 28.27 |
| Support Level | $79.52 | N/A |
| Resistance Level | $109.57 | $5.99 |
| Average True Range (ATR) | 2.59 | 0.08 |
| MACD | -0.93 | -0.03 |
| Stochastic Oscillator | 62.50 | 26.00 |
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, the Netherlands, and Ukraine. It has three main reportable segments: Turkcell Turkiye, Techfin, and Other. The Turkcell Turkiye segment, which derives the majority of revenue, comprises mainly telecommunication and technology services activities.